Skip to main content
SpringerLink
Log in

Relapse Rate as a Major Determinant of Drug Selection in Peptic Ulcer Therapy

  • Leading Article
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Abbrachio MP, Baldlini W, Cavallaro A, Adamoli P, Fittipaldi M, et al. Blood and brain levels of bismuth after oral or parenteral administration of TDB to rats. Neurotoxicology 6: 139–144, 1985

    Google Scholar 

  • Blackford JM, Bowers JM. A comparison of the late results of ambulatory and hospital treatment of peptic ulcer. American Journal of Medical Science 177: 51–58, 1929

    Article  Google Scholar 

  • Doessel DP, Gammie GJ. Cimetidine and ulcer surgery. Medical Journal of Australia 143: 16–19, 1985

    PubMed  CAS  Google Scholar 

  • Dolby JM, Webster ADB, Borriello SP, Barclay FE, Bartholomew BA, et al. Bacterial colonization and nitrate concentration in the achlorhydric stomachs of patients with primary hypogammaglobinaemia, or classical pernicious anaemia. Scandinavian Journal of Gastroenterology 19: 105–110, 1984

    PubMed  CAS  Google Scholar 

  • Hazell SL, Lee A. Campylobacter pyloridis, urease, hydrogen ion back diffusion and gastric ulcers. Lancet 2: 15–17, 1986

    Article  PubMed  CAS  Google Scholar 

  • Hill M. Normal and pathological microbial flora of the upper gastrointestinal tract. Scandinavian Journal of Gastroenterology 20(Suppl. 111): 1–5, 1985

    Article  Google Scholar 

  • Loiseau P, Henry P, Jallon P, Legroux M. Encephalopathies myocloniques iatrogenes aux sels de bismuth. Journal of the Neurological Sciences 27: 133–143, 1976

    Article  PubMed  CAS  Google Scholar 

  • Malmros H, Heirtonn T. A post-investigation of 687 medically treated cases of peptic ulcer. Acta Medica Scandinavia 133: 229–252, 1949

    Article  CAS  Google Scholar 

  • Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1: 1311–1315, 1984

    Article  PubMed  CAS  Google Scholar 

  • McLean AJ, Harcourt DM, McCarthy PG, Dudley FJ, McNeil JJ. Relative effectiveness and costs of anti-ulcer medications as a basis for rational prescribing. Medical Journal of Australia 146: 314–438, 1987a

    Google Scholar 

  • McLean AJ, Harcourt DM, McNeil JJ. A two-state model of patient populations with peptic ulcer — implications for drug choice and clinical trial design. Clinical Pharmacology and Therapeutics 41: 226, 1987b

    Google Scholar 

  • McLean AJ, Harrison PM, Bryne AJ, McCarthy PG, Dudley FJ. Relapse rates are more important than healing rates in determining the long-term outcome of duodenal ulcer therapy. Gastroenterology 89: 480–482, 1985a

    PubMed  CAS  Google Scholar 

  • McLean AJ, Harrison PM, Ioannides-Demos L, Bryne AJ, McCarthy PG, et al. Microbes, peptic ulcer, and relapse rates with different drugs. Lancet 2: 525–526, 1984

    Article  PubMed  CAS  Google Scholar 

  • McLean AJ, Harrison PM, Ioannides-Demos L, Bryne AJ, McCarthy PG, et al. The choice of ulcer healing agent influences duodenal ulcer relapse rate and long-term clinical outcome. Australian and New Zealand Journal of Medicine 15: 367–374, 1985b

    Article  PubMed  CAS  Google Scholar 

  • McLean AJ, McCarthy PG, Dudley FJ. Cytoprotective agents and ulcer relapse. Medical Journal of Australia 142 (Suppl.): S25–28, 1985c

    CAS  Google Scholar 

  • Miller JP, Faragher EB. Relapse of duodenal ulcer: does it really matter which drug is used in initial treatment? British Medical Journal 293: 1117–1118, 1986

    Article  PubMed  CAS  Google Scholar 

  • Porro BG, Lazzaroni M, Parente F, Petrillo M. The influence of colloidal bismuth subcitrate on duodenal ulcer relapse. Scandinavian Journal of Gastroenterology 21(Suppl. 122): 35–38, 1986

    Article  Google Scholar 

  • Porro BG, Lazzaroni M, Petrillo M, deNicola C. Relapse rates in duodenal ulcer patients formerly treated with bismuth subcitrate or maintained with cimetidine. Lancet 2: 698, 1984

    Article  Google Scholar 

  • Pounder RE. Model of medical treatment for duodenal ulcer. Lancet 1: 29–30, 1981

    Article  PubMed  CAS  Google Scholar 

  • Ruddell WSJ, Axon ATR, Findlay JM, Bartholomew BA, Hill MJ. Effect of cimetidine on the gastric bacterial flora. Lancet 1: 672–674, 1980

    PubMed  CAS  Google Scholar 

  • Ruffin JM, Texter Jr EC, Carter DD, Baylin GJ. Role of anticholinergic drugs in treatment of peptic ulcer. Journal of the American Medical Association 153: 1159–1161, 1953

    Article  PubMed  CAS  Google Scholar 

  • Supino-Viterbo V, Sicard C, Risvegliato M, Rancurel G, Buge A. Toxic encephalopathy due to ingestion of bismuth salts: clinical and EEG studies of 45 patients. Journal of Neurology, Neurosurgery and Psychiatry 40: 748–752, 1977

    Article  CAS  Google Scholar 

  • Talbot JH. A biographical history of medicine: excerpts and essays on the men and their work, p. 763, Grune and Stratton, New York, 1970

    Google Scholar 

  • Thomas DW, Hartlry TF, Coyle P, Sobecki S. Clinical and laboratory investigations of the metabolism of bismuth containing Pharmaceuticals by man and dogs. In Clinical chemistry and chemical toxicology of metals, pp. 293–296, Biomedical Press, Elsevier/North Holland, 1977

    Google Scholar 

  • Zoltan G, Klassen CD. Disposition of metals in rats: a comparative study of faecal, urinary and biliary excretion and tissue distribution of eighteen metals. Toxicology and Applied Pharmacology 85: 24–38, 1986

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinical Pharmacology Department and Gastroenterology Service, Alfred Hospital, Commercial Road, Prahran, Melbourne, Victoria, 3181, Australia

    Allan J. McLean (Director of Clinical Pharmacology), Diana M. Harcourt & John J. McNeil

  2. Departments of Social and Preventive Medicine, Medicine and Pharmacology, Monash University, Melbourne, Australia

    Diana M. Harcourt & John J. McNeil

Authors
  1. Allan J. McLean
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Diana M. Harcourt
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. John J. McNeil
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

McLean, A.J., Harcourt, D.M. & McNeil, J.J. Relapse Rate as a Major Determinant of Drug Selection in Peptic Ulcer Therapy. Drugs 35, 329–333 (1988). https://doi.org/10.2165/00003495-198835040-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-198835040-00001

Keywords

Search

Navigation